Tumor-associated macrophages derived exosomal circPLK1 promotes resistance to EGFR inhibitor osimertinib in non-small cell lung cancer

Authors

Institutions

Publication Details

Journal
Discover Oncology
Published
2025-07-01
DOI
https://doi.org/10.1007/s12672-025-03025-w
Citations
3
Primary Topic
Circular RNAs in diseases
Type
article
Field-Weighted Citation Impact
2.42

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tumor-associated macrophages derived exosomal circPLK1 promotes resistance to EGFR inhibitor osimertinib in non-small cell lung cancer

Chuankui Li, Zuyi Wang, Xinyu Sun
3 citations
Discover Oncology
Circular RNAs in diseases
2.42
article

Tumor-associated macrophages derived exosomal circPLK1 promotes resistance to EGFR inhibitor osimertinib in non-small cell lung cancer

Chuankui Li, Zuyi Wang, Xinyu Sun
article en
3 citations

Abstract

No abstract available for this paper.
Discover OncologyVol. 16(1)
Bengbu Medical College (CN), First Affiliated Hospital of Bengbu Medical College (CN)
Bengbu Medical College
Good health and well-being
Openalex Percentile: Top 11%
Circular RNAs in diseases
2.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Tumor-associated macrophages derived exosomal circPLK1 promotes resistance to EGFR inhibitor osimertinib in non-small cell lung cancer — Chuankui Li, Zuyi Wang, et al. · Discover Oncology (2025) | TGRS Research Map | TGRS